AMEDISYS INC·4

Aug 4, 9:01 PM ET

Gerard Christopher 4

4 · AMEDISYS INC · Filed Aug 4, 2021

Insider Transaction Report

Form 4
Period: 2021-08-02
Gerard Christopher
Chief Operating Officer
Transactions
  • Sale

    Common Stock

    2021-08-02$257.44/sh100$25,74439,006 total
  • Sale

    Common Stock

    2021-08-02$261.73/sh500$130,86538,056 total
  • Sale

    Common Stock

    2021-08-02$263.19/sh200$52,63837,856 total
  • Sale

    Common Stock

    2021-08-02$260.66/sh450$117,29738,556 total
Holdings
  • Common Stock

    (indirect: By 401(k))
    279
Footnotes (5)
  • [F1]These sales were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person.
  • [F2]The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $260.38 to $261.16, inclusive. The reporting person undertakes to provide to Amedisys, Inc. (the "Issuer"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4.
  • [F3]The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $261.39 to $262.34, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (3) to this Form 4.
  • [F4]The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $263.16 to $263.215, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (4) to this Form 4.
  • [F5]The information in this report is based on a plan statement dated as of June 30, 2021.

Documents

1 file
  • 4
    wf-form4_162812522559440.xmlPrimary

    FORM 4